Summary
Baylor Research Institute (Baylor) a subsidiary of Baylor Scott & White Health is a medical research institute which offers a wide range of prevention therapies and treatments for various diseases and illness. It offers clinical trial facilities for various therapy areas. The institute’s research areas include allergy and immunology, asthma care, cancer care, diabetes, general surgery, heart and vascular health, metabolic disease, gynecology, among others. Baylor has collaborations with various research organizations worldwide. It is supported by philanthropy through the Baylor Health Care System Foundation and by grants from the National Institutes of Health and other national organizations. The institute caters its services to medical centers in Dallas, Fort Worth, Garland, Grapevine, Irving, Plano, Waxahachie, and Carrollton; the US. Baylor is headquartered in Dallas, Texas, the US.
Baylor Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Baylor Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Baylor Research Institute, Medical Devices Deals, 2011 to YTD 2017 9
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Baylor Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
TGen Enters into Research Agreement with Baylor Research Institute 12
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 13
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 14
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 15
Licensing Agreements 16
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 16
Ultragenyx Pharma Enters Into Licensing Agreement With Baylor Research Institute For Triheptanoin 17
Baylor Research Institute - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Baylor Research Institute, Pharmaceuticals & Healthcare, Key Facts 1
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Baylor Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Baylor Research Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Baylor Research Institute, Medical Devices Deals, 2011 to YTD 2017 9
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
TGen Enters into Research Agreement with Baylor Research Institute 12
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 13
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 14
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 15
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 16
Ultragenyx Pharma Enters Into Licensing Agreement With Baylor Research Institute For Triheptanoin 17
Baylor Research Institute, Key Competitors 19
Baylor Research Institute, Key Employees 20
List of Figures
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Baylor Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Baylor Research Institute, Medical Devices Deals, 2011 to YTD 2017 9